Fujii H - Search Results

1

Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan.

Nishi S, Hoshino J, Yamamoto S, Goto S, Fujii H, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y. Nishi S, et al. Among authors: fujii h. Nephrology (Carlton). 2018 Jul;23(7):640-645. doi: 10.1111/nep.13077. Nephrology (Carlton). 2018. PMID: 28556529

2

Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease.

Fujii H, Kono K, Goto S, Onishi T, Kawai H, Hirata K, Hattori K, Nakamura K, Endo F, Fukagawa M. Fujii H, et al. Am J Nephrol. 2009;30(6):527-35. doi: 10.1159/000250968. Epub 2009 Oct 16. Am J Nephrol. 2009. PMID: 19844084

3

Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.

Fujii H, Kono K, Nakai K, Goto S, Komaba H, Hamada Y, Shinohara M, Kitazawa R, Kitazawa S, Fukagawa M. Fujii H, et al. Am J Nephrol. 2010;31(4):342-52. doi: 10.1159/000297290. Epub 2010 Mar 12. Am J Nephrol. 2010. PMID: 20224273

4

Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.

Goto S, Fujii H, Hamada Y, Yoshiya K, Fukagawa M. Goto S, et al. Among authors: fujii h. Ther Apher Dial. 2010 Aug 1;14(4):417-23. doi: 10.1111/j.1744-9987.2010.00813.x. Ther Apher Dial. 2010. PMID: 20649763

5

The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.

Hamada Y, Kitazawa S, Kitazawa R, Kono K, Goto S, Komaba H, Fujii H, Yamamoto Y, Yamamoto H, Usami M, Fukagawa M. Hamada Y, et al. Among authors: fujii h. Endocrine. 2010 Dec;38(3):369-76. doi: 10.1007/s12020-010-9390-9. Epub 2010 Oct 23. Endocrine. 2010. PMID: 20972729

6

Effects of AST-120 on left ventricular mass in predialysis patients.

Nakai K, Fujii H, Kono K, Goto S, Fukagawa M, Nishi S. Nakai K, et al. Among authors: fujii h. Am J Nephrol. 2011;33(3):218-23. doi: 10.1159/000324354. Epub 2011 Feb 18. Am J Nephrol. 2011. PMID: 21335967

7

Uremic toxins and oral adsorbents.

Goto S, Yoshiya K, Kita T, Fujii H, Fukagawa M. Goto S, et al. Among authors: fujii h. Ther Apher Dial. 2011 Apr;15(2):132-4. doi: 10.1111/j.1744-9987.2010.00891.x. Epub 2011 Mar 8. Ther Apher Dial. 2011. PMID: 21426503 Review.

8

Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients.

Takeda Y, Komaba H, Goto S, Fujii H, Umezu M, Hasegawa H, Fujimori A, Nishioka M, Nishi S, Fukagawa M. Takeda Y, et al. Among authors: fujii h. Am J Nephrol. 2011;33(5):421-6. doi: 10.1159/000327019. Epub 2011 Apr 19. Am J Nephrol. 2011. PMID: 21502756

9

Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.

Goto S, Komaba H, Moriwaki K, Fujimori A, Shibuya K, Nishioka M, Kim JI, Yoshiya K, Shin J, Hasegawa H, Taniguchi M, Fujii H, Nishi S, Kamae I, Fukagawa M. Goto S, et al. Among authors: fujii h. Clin J Am Soc Nephrol. 2011 Jun;6(6):1375-84. doi: 10.2215/CJN.08841010. Epub 2011 May 5. Clin J Am Soc Nephrol. 2011. PMID: 21551021 Free PMC article. Clinical Trial.

10

Comparison between whole and intact parathyroid hormone assays.

Taniguchi M, Tanaka M, Hamano T, Nakanishi S, Fujii H, Kato H, Koiwa F, Ando R, Kimata N, Akiba T, Kono T, Yokoyama K, Shigematsu T, Kakuta T, Kazama JJ, Tominaga Y, Fukagawa M. Taniguchi M, et al. Among authors: fujii h. Ther Apher Dial. 2011 Jun;15 Suppl 1:42-9. doi: 10.1111/j.1744-9987.2011.00926.x. Ther Apher Dial. 2011. PMID: 21595852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,055 results

Search Page

Filters